{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:37:11Z","timestamp":1793137031887,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biol"],"DOI":"10.1186\/s12915-025-02172-4","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:58:44Z","timestamp":1740751124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["ARv7 promotes the escape of prostate cancer cells from androgen deprivation therapy-induced senescence by mediating the SKP2\/p27 axis"],"prefix":"10.1186","volume":"23","author":[{"given":"Dian","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoge","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5008-6912","authenticated-orcid":false,"given":"Chen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"3","key":"2172_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2172_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/aps.2014.18","volume":"36","author":"MH Tan","year":"2015","unstructured":"Tan MH, Li J, Xu HE, Melcher K, Yong EL. Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin. 2015;36(1):3\u201323.","journal-title":"Acta Pharmacol Sin"},{"issue":"Suppl 1","key":"2172_CR3","first-page":"S3","volume":"9 Suppl 1","author":"MA Perlmutter","year":"2007","unstructured":"Perlmutter MA, Lepor H. Androgen deprivation therapy in the treatment of advanced prostate cancer. Rev Urol. 2007;9 Suppl 1(Suppl 1):S3\u20138.","journal-title":"Rev Urol"},{"issue":"49","key":"2172_CR4","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1038\/onc.2013.206","volume":"32","author":"T Karantanos","year":"2013","unstructured":"Karantanos T, Corn PG, Thompson TC. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches. Oncogene. 2013;32(49):5501\u201311.","journal-title":"Oncogene"},{"issue":"5","key":"2172_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12032-016-0759-3","volume":"33","author":"L Graham","year":"2016","unstructured":"Graham L, Schweizer MT. Targeting persistent androgen receptor signaling in castration-resistant prostate cancer. Med Oncol. 2016;33(5):44.","journal-title":"Med Oncol"},{"issue":"1","key":"2172_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.urolonc.2008.03.021","volume":"27","author":"X Yuan","year":"2009","unstructured":"Yuan X, Balk SP. Mechanisms mediating androgen receptor reactivation after castration. Urol Oncol. 2009;27(1):36\u201341.","journal-title":"Urol Oncol"},{"issue":"11","key":"2172_CR7","doi-asserted-by":"publisher","first-page":"18550","DOI":"10.18632\/oncotarget.14537","volume":"8","author":"KM Wadosky","year":"2017","unstructured":"Wadosky KM, Koochekpour S. Androgen receptor splice variants and prostate cancer: from bench to bedside. Oncotarget. 2017;8(11):18550\u201376.","journal-title":"Oncotarget"},{"issue":"3","key":"2172_CR8","first-page":"178","volume":"2","author":"C Lu","year":"2013","unstructured":"Lu C, Luo J. Decoding the androgen receptor splice variants. Transl Androl Urol. 2013;2(3):178\u201386.","journal-title":"Transl Androl Urol"},{"issue":"4","key":"2172_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ajur.2016.08.003","volume":"3","author":"J Xu","year":"2016","unstructured":"Xu J, Qiu Y. Role of androgen receptor splice variants in prostate cancer metastasis. Asian J Urol. 2016;3(4):177\u201384.","journal-title":"Asian J Urol"},{"issue":"1","key":"2172_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clgc.2019.09.015","volume":"18","author":"T Zhang","year":"2020","unstructured":"Zhang T, Karsh LI, Nissenblatt MJ, Canfield SE. Androgen receptor splice variant, AR-V7, as a biomarker of resistance to androgen axis-targeted therapies in advanced prostate cancer. Clin Genitourin Cancer. 2020;18(1):1\u201310.","journal-title":"Clin Genitourin Cancer"},{"issue":"11","key":"2172_CR11","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","volume":"371","author":"ES Antonarakis","year":"2014","unstructured":"Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med. 2014;371(11):1028\u201338.","journal-title":"N Engl J Med"},{"issue":"14","key":"2172_CR12","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1158\/0008-5472.CAN-11-3892","volume":"72","author":"R Hu","year":"2012","unstructured":"Hu R, Lu C, Mostaghel EA, Yegnasubramanian S, Gurel M, Tannahill C, et al. Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer. Cancer Res. 2012;72(14):3457\u201362.","journal-title":"Cancer Res"},{"issue":"2","key":"2172_CR13","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.juro.2014.08.043","volume":"193","author":"J Lu","year":"2015","unstructured":"Lu J, Lonergan PE, Nacusi LP, Wang L, Schmidt LJ, Sun Z, et al. The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells. J Urol. 2015;193(2):690\u20138.","journal-title":"J Urol"},{"issue":"4","key":"2172_CR14","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/nar\/gkx1306","volume":"46","author":"Y He","year":"2018","unstructured":"He Y, Lu J, Ye Z, Hao S, Wang L, Kohli M, et al. Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer. Nucleic Acids Res. 2018;46(4):1895\u2013911.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2172_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/pros.22571","volume":"73","author":"JA Ewald","year":"2013","unstructured":"Ewald JA, Desotelle JA, Church DR, Yang B, Huang W, Laurila TA, et al. Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo. Prostate. 2013;73(4):337\u201345.","journal-title":"Prostate"},{"issue":"Pt B","key":"2172_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jsbmb.2016.06.007","volume":"165","author":"H Kawata","year":"2017","unstructured":"Kawata H, Kamiakito T, Nakaya T, Komatsubara M, Komatsu K, Morita T, et al. Stimulation of cellular senescent processes, including secretory phenotypes and anti-oxidant responses, after androgen deprivation therapy in human prostate cancer. J Steroid Biochem Mol Biol. 2017;165(Pt B):219\u201327.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"2172_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","volume":"18","author":"W Huang","year":"2022","unstructured":"Huang W, Hickson LJ, Eirin A, Kirkland JL, Lerman LO. Cellular senescence: the good, the bad and the unknown. Nat Rev Nephrol. 2022;18(10):611\u201327.","journal-title":"Nat Rev Nephrol"},{"key":"2172_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.dnarep.2018.07.008","volume":"69","author":"M Abbastabar","year":"2018","unstructured":"Abbastabar M, Kheyrollah M, Azizian K, Bagherlou N, Tehrani SS, Maniati M, et al. Multiple functions of p27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: a double-edged sword protein. DNA Repair (Amst). 2018;69:63\u201372.","journal-title":"DNA Repair (Amst)"},{"issue":"9","key":"2172_CR19","doi-asserted-by":"publisher","first-page":"6684","DOI":"10.18632\/oncotarget.3246","volume":"6","author":"HP Lin","year":"2015","unstructured":"Lin HP, Lin CY, Huo C, Hsiao PH, Su LC, Jiang SS, et al. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1. Oncotarget. 2015;6(9):6684\u2013707.","journal-title":"Oncotarget"},{"issue":"10","key":"2172_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109170","volume":"9","author":"JM Kokontis","year":"2014","unstructured":"Kokontis JM, Lin HP, Jiang SS, Lin CY, Fukuchi J, Hiipakka RA, et al. Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2. PLoS One. 2014;9(10): e109170.","journal-title":"PLoS One"},{"key":"2172_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/1471-2407-10-541","volume":"10","author":"W Taylor","year":"2010","unstructured":"Taylor W, Mathias A, Ali A, Ke H, Stoynev N, Shilkaitis A, et al. p27(Kip1) deficiency promotes prostate carcinogenesis but does not affect the efficacy of retinoids in suppressing the neoplastic process. BMC Cancer. 2010;10:541.","journal-title":"BMC Cancer"},{"issue":"4","key":"2172_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc2347","volume":"8","author":"IM Chu","year":"2008","unstructured":"Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 2008;8(4):253\u201367.","journal-title":"Nat Rev Cancer"},{"key":"2172_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Copp\u00e9","year":"2010","unstructured":"Copp\u00e9 JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99\u2013118.","journal-title":"Annu Rev Pathol"},{"key":"2172_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114765","volume":"193","author":"V Carpenter","year":"2021","unstructured":"Carpenter V, Saleh T, Min Lee S, Murray G, Reed J, Souers A, et al. Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy. Biochem Pharmacol. 2021;193: 114765.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"2172_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068003","volume":"8","author":"DG Burton","year":"2013","unstructured":"Burton DG, Giribaldi MG, Munoz A, Halvorsen K, Patel A, Jorda M, et al. Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells. PLoS One. 2013;8(6): e68003.","journal-title":"PLoS One"},{"issue":"2","key":"2172_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.molcel.2018.08.029","volume":"72","author":"L Cai","year":"2018","unstructured":"Cai L, Tsai YH, Wang P, Wang J, Li D, Fan H, et al. ZFX mediates non-canonical oncogenic functions of the androgen receptor splice variant 7 in castrate-resistant prostate cancer. Mol Cell. 2018;72(2):341\u201354.e6.","journal-title":"Mol Cell"},{"key":"2172_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100276","volume":"296","author":"B Yu","year":"2021","unstructured":"Yu B, Liu Y, Luo H, Fu J, Li Y, Shao C. Androgen receptor splicing variant 7 (ARV7) inhibits docetaxel sensitivity by inactivating the spindle assembly checkpoint. J Biol Chem. 2021;296: 100276.","journal-title":"J Biol Chem"},{"issue":"1","key":"2172_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13578-022-00941-0","volume":"12","author":"J Kallenbach","year":"2022","unstructured":"Kallenbach J, Atri Roozbahani G, Heidari Horestani M, Baniahmad A. Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer. Cell Biosci. 2022;12(1):200.","journal-title":"Cell Biosci"},{"issue":"9","key":"2172_CR29","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200190R","volume":"36","author":"H Luo","year":"2022","unstructured":"Luo H, Liu Y, Li Y, Zhang C, Yu B, Shao C. Androgen receptor splicing variant 7 (ARv7) promotes DNA damage response in prostate cancer cells. FASEB J. 2022;36(9): e22495.","journal-title":"FASEB J"},{"issue":"1\u20132","key":"2172_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.drup.2012.01.002","volume":"15","author":"RR Gordon","year":"2012","unstructured":"Gordon RR, Nelson PS. Cellular senescence and cancer chemotherapy resistance. Drug Resist Updat. 2012;15(1\u20132):123\u201331.","journal-title":"Drug Resist Updat"},{"issue":"10","key":"2172_CR31","doi-asserted-by":"publisher","first-page":"735","DOI":"10.18632\/aging.100209","volume":"2","author":"MA Smit","year":"2010","unstructured":"Smit MA, Peeper DS. Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths. Aging (Albany NY). 2010;2(10):735\u201341.","journal-title":"Aging (Albany NY)"},{"issue":"7686","key":"2172_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature25167","volume":"553","author":"M Milanovic","year":"2018","unstructured":"Milanovic M, Fan DNY, Belenki D, D\u00e4britz JHM, Zhao Z, Yu Y, et al. Senescence-associated reprogramming promotes cancer stemness. Nature. 2018;553(7686):96\u2013100.","journal-title":"Nature"},{"issue":"2","key":"2172_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188424","volume":"1874","author":"VJ Carpenter","year":"2020","unstructured":"Carpenter VJ, Patel BB, Autorino R, Smith SC, Gewirtz DA, Saleh T. Senescence and castration resistance in prostate cancer: a review of experimental evidence and clinical implications. Biochim Biophys Acta Rev Cancer. 2020;1874(2): 188424.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"5","key":"2172_CR34","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3892\/ijmm.2017.3125","volume":"40","author":"P Yu","year":"2017","unstructured":"Yu P, Duan X, Cheng Y, Liu C, Chen Y, Liu W, et al. Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase. Int J Mol Med. 2017;40(5):1426\u201334.","journal-title":"Int J Mol Med"},{"issue":"6","key":"2172_CR35","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1593\/neo.11182","volume":"13","author":"Z Pernicov\u00e1","year":"2011","unstructured":"Pernicov\u00e1 Z, Slab\u00e1kov\u00e1 E, Kharaishvili G, Bouchal J, Kr\u00e1l M, Kunick\u00e1 Z, et al. Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2. Neoplasia. 2011;13(6):526\u201336.","journal-title":"Neoplasia"},{"issue":"48","key":"2172_CR36","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1038\/onc.2015.41","volume":"34","author":"DJ Barakat","year":"2015","unstructured":"Barakat DJ, Zhang J, Barberi T, Denmeade SR, Friedman AD, Paz-Priel I. CCAAT\/enhancer binding protein \u03b2 controls androgen-deprivation-induced senescence in prostate cancer cells. Oncogene. 2015;34(48):5912\u201322.","journal-title":"Oncogene"},{"issue":"2","key":"2172_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cell.2006.11.047","volume":"128","author":"M Grimmler","year":"2007","unstructured":"Grimmler M, Wang Y, Mund T, Cilensek Z, Keidel EM, Waddell MB, et al. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell. 2007;128(2):269\u201380.","journal-title":"Cell"},{"issue":"Pt 2","key":"2172_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.semcancer.2020.01.013","volume":"67","author":"Z Cai","year":"2020","unstructured":"Cai Z, Moten A, Peng D, Hsu CC, Pan BS, Manne R, et al. The Skp2 pathway: a critical target for cancer therapy. Semin Cancer Biol. 2020;67(Pt 2):16\u201333.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"2172_CR39","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.1038\/s41598-020-63716-y","volume":"10","author":"HH Wang","year":"2020","unstructured":"Wang HH, Lee YN, Su CH, Shu KT, Liu WT, Hsieh CL, et al. S-phase kinase-associated protein-2 rejuvenates senescent endothelial progenitor cells and induces angiogenesis in vivo. Sci Rep. 2020;10(1):6646.","journal-title":"Sci Rep"},{"issue":"3","key":"2172_CR40","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1074\/jbc.M111.323303","volume":"287","author":"Z Fang","year":"2012","unstructured":"Fang Z, Zhang T, Dizeyi N, Chen S, Wang H, Swanson KD, et al. Androgen receptor enhances p27 degradation in prostate cancer cells through rapid and selective TORC2 activation. J Biol Chem. 2012;287(3):2090\u20138.","journal-title":"J Biol Chem"},{"issue":"4","key":"2172_CR41","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/pros.22763","volume":"74","author":"B Li","year":"2014","unstructured":"Li B, Lu W, Yang Q, Yu X, Matusik RJ, Chen Z. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt\/mTOR pathways in prostate cancer. Prostate. 2014;74(4):421\u201332.","journal-title":"Prostate"},{"key":"2172_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100890","volume":"38","author":"AH Rezaeian","year":"2023","unstructured":"Rezaeian AH, Phan LM, Zhou X, Wei W, Inuzuka H. Pharmacological inhibition of the SKP2\/p300 signaling axis restricts castration-resistant prostate cancer. Neoplasia. 2023;38: 100890.","journal-title":"Neoplasia"},{"issue":"1","key":"2172_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40364-023-00481-w","volume":"11","author":"N W\u00fcstmann","year":"2023","unstructured":"W\u00fcstmann N, Seitzer K, Humberg V, Vieler J, Grundmann N, Steinestel J, et al. Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer. Biomark Res. 2023;11(1):37.","journal-title":"Biomark Res"},{"issue":"6","key":"2172_CR44","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41388-020-01585-5","volume":"40","author":"CM Roggero","year":"2021","unstructured":"Roggero CM, Jin L, Cao S, Sonavane R, Kopplin NG, Ta HQ, et al. A detailed characterization of stepwise activation of the androgen receptor variant 7 in prostate cancer cells. Oncogene. 2021;40(6):1106\u201317.","journal-title":"Oncogene"},{"key":"2172_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1021845","volume":"12","author":"M Labaf","year":"2022","unstructured":"Labaf M, Li M, Ting L, Karno B, Zhang S, Gao S, et al. Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2. Front Oncol. 2022;12: 1021845.","journal-title":"Front Oncol"},{"issue":"19","key":"2172_CR46","doi-asserted-by":"publisher","first-page":"10929","DOI":"10.1093\/nar\/gkac861","volume":"50","author":"J Wang","year":"2022","unstructured":"Wang J, Park KS, Yu X, Gong W, Earp HS, Wang GG, et al. A cryptic transactivation domain of EZH2 binds AR and AR\u2019s splice variant, promoting oncogene activation and tumorous transformation. Nucleic Acids Res. 2022;50(19):10929\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"26","key":"2172_CR47","doi-asserted-by":"publisher","first-page":"6810","DOI":"10.1073\/pnas.1718811115","volume":"115","author":"Z Chen","year":"2018","unstructured":"Chen Z, Wu D, Thomas-Ahner JM, Lu C, Zhao P, Zhang Q, et al. Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13. Proc Natl Acad Sci U S A. 2018;115(26):6810\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2172_CR48","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/pros.20677","volume":"68","author":"JM D'Antonio","year":"2008","unstructured":"D\u2019Antonio JM, Ma C, Monzon FA, Pflug BR. Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence. Prostate. 2008;68(7):698\u2013714.","journal-title":"Prostate"},{"issue":"7406","key":"2172_CR49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012;487(7406):239\u201343.","journal-title":"Nature"},{"issue":"3","key":"2172_CR50","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1172\/JCI66666","volume":"123","author":"C Cai","year":"2013","unstructured":"Cai C, Wang H, He HH, Chen S, He L, Ma F, et al. ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer. J Clin Invest. 2013;123(3):1109\u201322.","journal-title":"J Clin Invest"}],"container-title":["BMC Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-025-02172-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12915-025-02172-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-025-02172-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T14:35:56Z","timestamp":1740753356000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiol.biomedcentral.com\/articles\/10.1186\/s12915-025-02172-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1186\/s12915-025-02172-4","relation":{},"ISSN":["1741-7007"],"issn-type":[{"value":"1741-7007","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"3 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the data generated using human samples were downloaded from publicly available database. This study does not involve the use of any human or animal samples or the participation of human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}